SB 249 — AN ACT IMPLEMENTING THE RECOMMENDATIONS OF THE BREAST HEALTH AND BREAST CANCER AWARENESS WORKING GROUP.

Senate General Assembly RaisedFile Bill No.

24996 February Session, 2022 LCOSenate Bill No.

2167249 ReferredSenate, toMarch 23, 2022 The Committee on PUBLICPublic HEALTHHealth Introducedreported by:through SEN.

(PH)DAUGHERTY ANABRAMS ACTof IMPLEMENTINGthe THE13th RECOMMENDATIONSDist., OFChairperson THEof BREASTthe HEALTHCommittee ANDon BREASTthe CANCERpart AWARENESSof WORKINGthe GROUP.Senate, that the bill ought to pass.

AN ACT IMPLEMENTING THE RECOMMENDATIONS OF THE BREAST HEALTH AND BREAST CANCER AWARENESS WORKING GROUP.

(2) "Cervical cancer screening and referral services" means necessary cervical cancer screening services and referral services for a procedure intended to treat cancer of the human cervix, including, but not limited to, surgery, radiation therapy, cryotherapy, electrocoagulation and relatedSB249 medical/ follow-upFile services.No.

LCO96 21671 \\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-00249-R01SB249 ofFile 3 SB.docx Raised Bill No.

24996 (3)related "Tomosynthesis"medical meansfollow-up aservices. digital x-ray mammogram that creates two-dimensional and three-dimensional images of the breasts.

(3) "Tomosynthesis" means a digital x-ray mammogram that creates two-dimensional and three-dimensional images of the breasts.

(2) Development of professional education programs, including the benefits of early detection of breast cancer and the recommended frequency of mammography and the benefits of early detection of cervicalSB249 cancer/ andFile the recommended frequency of pap tests and tests LCO 2167 {\\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-00242 of 3 R01-SB.docx } Raised Bill No.

24996 for2 humanSB249 papillomavirus;File No.

96 cervical cancer and the recommended frequency of pap tests and tests for human papillomavirus;

Section 1 October 1, 2022 19a-266 PH Joint Favorable LCOSB249 2167/ {\\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-00249-3File ofNo. 3 R01-SB.docx }

96 3 SB249 File No.

96 The following Fiscal Impact Statement and Bill Analysis are prepared for the benefit of the members of the General Assembly, solely for purposes of information, summarization and explanation and do not represent the intent of the General Assembly or either chamber thereof for any purpose.

In general, fiscal impacts are based upon a variety of informational sources, including the analyst’s professional knowledge.

Whenever applicable, agency data is consulted as part of the analysis, however final products do not necessarily reflect an assessment from any specific department.

OFA Fiscal Note State Impact:

None Municipal Impact:

None Explanation This bill makes certain changes to the Department of Public Health’s breast and cervical cancer early detection and treatment referral program, which provides screening and related services to certain income-eligiblewomen.Thebillisnotanticipatedtohaveafiscalimpact as screening for tomosynthesis and testing for human papillomavirus (HPV) are currently being performed.

The Out Years State Impact:

None Municipal Impact:

None SB249 / File No.

96 4 SB249 File No.

96 OLR Bill Analysis SB 249 AN ACT IMPLEMENTING THE RECOMMENDATIONS OF THE BREAST HEALTH AND BREAST CANCER AWARENESS WORKING GROUP.

SUMMARY This bill makes various changes to the Department of Public Health’s (DPH) breast and cervical cancer early detection and treatment referral program, which provides screening and related services to certain income-eligible women.

The bill:

1.

requires the program to give priority consideration to women in minority communities with higher rates of breast cancer and cervical cancer than the general population, 2.

requires breast cancer screening through the program to include tomosynthesis where possible, 3.

adds human papillomavirus (HPV) tests to the program’s services, and 4.

makes conforming changes by adding references to tomosynthesis and HPV tests to the educational and outreach components of the program.

EFFECTIVE DATE:

October 1, 2022 BREAST AND CERVICAL CANCER EARLY DETECTION AND TREATMENT REFERRAL PROGRAM By law, this program provides services, within existing appropriations and through contracts with health care providers, to women who (1) have incomes at or below 250% of the federal poverty level, (2) are 21 to 64 years old, and (3) lack health insurance coverage SB249 / File No.

96 5 SB249 File No.

96 for breast cancer screening mammography or cervical cancer screening services.

Under existing law, the program’s services include clinical breast exams, screening mammograms, and pap tests.

The bill requires the program’s mammography services to include, where possible, tomosynthesis, which it defines as a digital x-ray mammogram that creates two- and three-dimensional images of the breasts.

The bill additionally requires the program to include HPV tests.

As under existing law, these services must be provided as recommended by the U.S.